-+ 0.00%
-+ 0.00%
-+ 0.00%

Autonomix long-term pancreatic cancer pain data accepted for presentation at DDW 2026

PUBT·04/29/2026 12:45:20
Listen to the news
Autonomix long-term pancreatic cancer pain data accepted for presentation at DDW 2026
  • Autonomix Medical announced abstract acceptance at Digestive Disease Week 2026 for long-term data on its transvascular radiofrequency ablation approach for pancreatic cancer pain mitigation.
  • Results will be presented May 2-5, 2026, in Chicago and virtually.
  • Long-term outcomes indicate the procedure can mitigate severe pain in pancreatic adenocarcinoma by disrupting nerve signaling pathways tied to pain transmission.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604290845PRIMZONEFULLFEED9709039) on April 29, 2026, and is solely responsible for the information contained therein.